Frizzled 1 and Wnt1 as new potential therapeutic targets in the traumatically injured spinal cord
- 3 January 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cellular and Molecular Life Sciences
- Vol. 77 (22), 4631-4662
- https://doi.org/10.1007/s00018-019-03427-4
Abstract
Despite the experimental evidence pointing to a significant role of the Wnt family of proteins in physiological and pathological rodent spinal cord functioning, its potential relevance in the healthy and traumatically injured human spinal cord as well as its therapeutic potential in spinal cord injury (SCI) are still poorly understood. To get further insight into these interesting issues, we first demonstrated by quantitative Real-Time PCR and simple immunohistochemistry that detectable mRNA expression of most Wnt components, as well as protein expression of all known Wnt receptors, can be found in the healthy human spinal cord, supporting its potential involvement in human spinal cord physiology. Moreover, evaluation of Frizzled (Fz) 1 expression by double immunohistochemistry showed that its spatio-temporal and cellular expression pattern in the traumatically injured human spinal cord is equivalent to that observed in a clinically relevant model of rat SCI and suggests its potential involvement in SCI progression/outcome. Accordingly, we found that long-term lentiviral-mediated overexpression of the Fz1 ligand Wnt1 after rat SCI improves motor functional recovery, increases myelin preservation and neuronal survival, and reduces early astroglial reactivity and NG2+ cell accumulation, highlighting the therapeutic potential of Wnt1 in this neuropathological situation.Keywords
Funding Information
- Fondo de Investigaciones Sanitarias-Instituto de Salud Carlos III (PI12/02895)
- Ministerio de Ciencia, Innovación y Universidades (RTI2018-097775-B-I00)
This publication has 140 references indexed in Scilit:
- Beneficial compaction of spinal cord lesion by migrating astrocytes through glycogen synthase kinase‐3 inhibitionEMBO Molecular Medicine, 2011
- Reduction in expression of the astrocyte glutamate transporter, GLT1, worsens functional and histological outcomes following traumatic spinal cord injuryGlia, 2011
- Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's diseaseNeurobiology of Disease, 2011
- WNT signaling in activated microglia is proinflammatoryGlia, 2010
- GSK3: a multifaceted kinase in Wnt signalingTrends in Biochemical Sciences, 2010
- Molecular dissection of reactive astrogliosis and glial scar formationTrends in Neurosciences, 2009
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Myelin Proteomics: Molecular Anatomy of an Insulating SheathMolecular Neurobiology, 2009
- Cellular demise and inflammatory microglial activation during β-amyloid toxicity are governed by Wnt1 and canonical signaling pathwaysCellular Signalling, 2007
- Genome-wide atlas of gene expression in the adult mouse brainNature, 2006